These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 11104795

  • 1. Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing.
    Bousquet C, Zatelli MC, Melmed S.
    J Clin Invest; 2000 Dec; 106(11):1417-25. PubMed ID: 11104795
    [Abstract] [Full Text] [Related]

  • 2. cAMP neuropeptide agonists induce pituitary suppressor of cytokine signaling-3: novel negative feedback mechanism for corticotroph cytokine action.
    Bousquet C, Chesnokova V, Kariagina A, Ferrand A, Melmed S.
    Mol Endocrinol; 2001 Nov; 15(11):1880-90. PubMed ID: 11682619
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Synergistic signaling by corticotropin-releasing hormone and leukemia inhibitory factor bridged by phosphorylated 3',5'-cyclic adenosine monophosphate response element binding protein at the Nur response element (NurRE)-signal transducers and activators of transcription (STAT) element of the proopiomelanocortin promoter.
    Mynard V, Latchoumanin O, Guignat L, Devin-Leclerc J, Bertagna X, Barré B, Fagart J, Coqueret O, Catelli MG.
    Mol Endocrinol; 2004 Dec; 18(12):2997-3010. PubMed ID: 15319449
    [Abstract] [Full Text] [Related]

  • 5. Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway.
    Ray DW, Ren SG, Melmed S.
    J Clin Invest; 1996 Apr 15; 97(8):1852-9. PubMed ID: 8621768
    [Abstract] [Full Text] [Related]

  • 6. Leukemia inhibitory factor regulates proopiomelanocortin transcription.
    Ray DW, Ren SG, Melmed S.
    Ann N Y Acad Sci; 1998 May 01; 840():162-73. PubMed ID: 9629248
    [Abstract] [Full Text] [Related]

  • 7. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
    Bousquet C, Susini C, Melmed S.
    J Clin Invest; 1999 Nov 01; 104(9):1277-85. PubMed ID: 10545526
    [Abstract] [Full Text] [Related]

  • 8. Critical role for STAT3 in murine pituitary adrenocorticotropin hormone leukemia inhibitory factor signaling.
    Bousquet C, Melmed S.
    J Biol Chem; 1999 Apr 16; 274(16):10723-30. PubMed ID: 10196143
    [Abstract] [Full Text] [Related]

  • 9. A common pro-opiomelanocortin-binding element mediates leukemia inhibitory factor and corticotropin-releasing hormone transcriptional synergy.
    Bousquet C, Ray DW, Melmed S.
    J Biol Chem; 1997 Apr 18; 272(16):10551-7. PubMed ID: 9099700
    [Abstract] [Full Text] [Related]

  • 10. Cell-specific pituitary gene expression profiles after treatment with leukemia inhibitory factor reveal novel modulators for proopiomelanocortin expression.
    Abbud RA, Kelleher R, Melmed S.
    Endocrinology; 2004 Feb 18; 145(2):867-80. PubMed ID: 14576184
    [Abstract] [Full Text] [Related]

  • 11. Opposing effects of pituitary leukemia inhibitory factor and SOCS-3 on the ACTH axis response to inflammation.
    Chesnokova V, Kariagina A, Melmed S.
    Am J Physiol Endocrinol Metab; 2002 May 18; 282(5):E1110-8. PubMed ID: 11934677
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Leukemia inhibitory factor (LIF) induces acute adrenocorticotrophic hormone (ACTH) secretion in fetal rhesus macaque primates: a novel dynamic test of pituitary function.
    Akita S, Conn PM, Melmed S.
    J Clin Endocrinol Metab; 1996 Nov 18; 81(11):4170-8. PubMed ID: 8923879
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Interleukin-11 stimulates proopiomelanocortin gene expression and adrenocorticotropin secretion in corticotroph cells: evidence for a redundant cytokine network in the hypothalamo-pituitary-adrenal axis.
    Auernhammer CJ, Melmed S.
    Endocrinology; 1999 Apr 18; 140(4):1559-66. PubMed ID: 10098488
    [Abstract] [Full Text] [Related]

  • 16. Reversal of glucocorticoids-dependent proopiomelanocortin gene inhibition by leukemia inhibitory factor.
    Latchoumanin O, Mynard V, Devin-Leclerc J, Dugué MA, Bertagna X, Catelli MG.
    Endocrinology; 2007 Jan 18; 148(1):422-32. PubMed ID: 17038560
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Corticotropin-releasing hormone stimulates proopiomelanocortin transcription by cFos-dependent and -independent pathways: characterization of an AP1 site in exon 1.
    Boutillier AL, Monnier D, Lorang D, Lundblad JR, Roberts JL, Loeffler JP.
    Mol Endocrinol; 1995 Jun 18; 9(6):745-55. PubMed ID: 8592520
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cytokine-dependent gp130 receptor subunit regulates human fetal pituitary adrenocorticotropin hormone and growth hormone secretion.
    Shimon I, Yan X, Ray DW, Melmed S.
    J Clin Invest; 1997 Jul 15; 100(2):357-63. PubMed ID: 9218512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.